Journal article
CRISPR-mediated Ophthalmic Genome Surgery
Current ophthalmology reports, Vol.5(3), pp.199-206
09/2017
DOI: 10.1007/s40135-017-0144-1
PMCID: PMC5613978
PMID: 28966884
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR) is a genome engineering system with great potential for clinical applications due to its versatility and programmability. This review highlights the development and use of CRISPR-mediated ophthalmic genome surgery in recent years.\nDiverse CRISPR techniques are in development to target a wide array of ophthalmic conditions, including inherited and acquired conditions. Preclinical disease modeling and recent successes in gene editing suggest potential efficacy of CRISPR as a therapeutic for inherited conditions. In particular, the treatment of Leber congenital amaurosis with CRISPR-mediated genome surgery is expected to reach clinical trials in the near future.\nTreatment options for inherited retinal dystrophies are currently limited. CRISPR-mediated genome surgery methods may be able to address this unmet need in the future.
Details
- Title: Subtitle
- CRISPR-mediated Ophthalmic Genome Surgery
- Creators
- Galaxy Y Cho - Department of Pathology & Cell Biology, Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY, USAYazeed Abdulla - School of Medicine, The University of Jordan, Amman, JordanJesse D Sengillo - State University of New York Downstate Medical Center, Brooklyn, NY, USASally Justus - Jonas Children's Vision Care, and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Columbia University Medical Center, New York, NY, USAKellie A Schaefer - Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USAAlexander G Bassuk - Department of Pediatrics and Neurology, University of Iowa, Iowa City, IA, USAStephen H Tsang - Jonas Children's Vision Care, and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Columbia University Medical Center, New York, NY, USAVinit B Mahajan - Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA
- Resource Type
- Journal article
- Publication Details
- Current ophthalmology reports, Vol.5(3), pp.199-206
- DOI
- 10.1007/s40135-017-0144-1
- PMID
- 28966884
- PMCID
- PMC5613978
- NLM abbreviation
- Curr Ophthalmol Rep
- ISSN
- 2167-4868
- eISSN
- 2167-4868
- Publisher
- United States
- Grant note
- R01 EY025225 / NEI NIH HHS\nR01 EY018213 / NEI NIH HHS\nP30 CA013696 / NCI NIH HHS\nR01 EY024698 / NEI NIH HHS\nR01 EY026682 / NEI NIH HHS\nR01 EY024665 / NEI NIH HHS\nF31 EY026789 / NEI NIH HHS\nR21 AG050437 / NIA NIH HHS\nP30 EY019007 / NEI NIH HHS
- Language
- English
- Date published
- 09/2017
- Academic Unit
- Neurology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Neurology (Pediatrics)
- Record Identifier
- 9984070332002771
Metrics
27 Record Views